Improving the Value of Immune-Based Therapies
Issues Impacting Stakeholder Adoption of Immuno-Oncology
New Standards of Care in the Management of Prostate Cancer
Payers Evaluate the Clinical Utility of Diagnostic Tests
Innovation and the Role of Alternative Markers of Efficacy
The Use and Implementation of Standardized Treatment Pathways
Arguments Taking Shape For and Against FDA Regulation of Diagnostic Tests
HHS Announces New Oncology Care Management Initiative
FDA Updates
Study Results Support Early Treatment With Abiraterone in Prostate Cancer
ASCO Announces Partner for CancerLinQ Platform
ASCO Demands Medicaid Reform
FDA Approves Palbociclib for Metastatic Breast Cancer
Reality Meets ASCO's Policy Statement on Medicaid Reform
Patient Cost-Sharing in Oncology and the Patient Access Network Foundation
Commission on Cancer and the Oncology Medical Home
Immuno-Oncology Poised to Revolutionize Patient Care
The Promise of Immuno-Oncology
Money Well Spent: the Need for Federal Funding in Cancer Research
